Minority Pipeline: Science's Race Between Education And Catastrophe

Things could be worse. When The Scientist dedicates an issue to "minorities in science," we don't scratch our heads in wonder at the oxymoron, though we might have 30 years ago. There are many minority men and women in the sciences today, but not nearly enough. African, Hispanic, and Native Americans are clearly underrepresented in our laboratories, medical schools, and research centers. Their small numbers in these places of science are a deficit today that threatens to become an unrecoverable

Written byJohn Diggs
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Things could be worse. When The Scientist dedicates an issue to "minorities in science," we don't scratch our heads in wonder at the oxymoron, though we might have 30 years ago. There are many minority men and women in the sciences today, but not nearly enough. African, Hispanic, and Native Americans are clearly underrepresented in our laboratories, medical schools, and research centers. Their small numbers in these places of science are a deficit today that threatens to become an unrecoverable loss in a few years.

I realize that restating a problem regrettably familiar to us in the sciences raises two questions: How many minorities in the sciences would be "enough," and what is the "loss"? The answers to these questions, as I will explain, are related. We may agree that enough representation of minorities in the sciences is proportional representation. This, in fact, has been the stated goal of public ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies